Williams Douglas E (CIK 0001184847)

Latest company ownership

BIIB - BIOGEN INC.
Role: EVP Research & Development
Shares held
11,817
Last filed at
Jun 22, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q1 2025Q4
Shares held
1,750
Last filed at
May 18, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 14, 2018 Aug 16, 2018 Ovid Therapeutics Inc. Director Buy 91.3 +5,000 100.00% ✗ $32.4K
Jun 19, 2015 Jun 22, 2015 BIOGEN INC. EVP Research & Development Sell 10.0 -3,841 -24.53% ✓ $1.6M
Feb 12, 2015 Feb 17, 2015 BIOGEN INC. EVP Research & Development Sell 20.0 -2,450 -7.45% ✗ $960.7K
Feb 8, 2015 Feb 10, 2015 BIOGEN INC. EVP Research & Development Sell 20.0 -1,634 -11.24% ✗ $656.9K
Feb 1, 2015 Feb 2, 2015 BIOGEN INC. EVP Research & Development Sell 20.0 -2,059 -15.68% ✗ $801.3K
Mar 19, 2014 Mar 21, 2014 BIOGEN INC. EVP Research & Development Sell 5.0 -3,505 -30.53% ✓ $1.2M
Feb 12, 2014 Feb 14, 2014 BIOGEN INC. EVP Research & Development Sell 20.0 -1,685 -12.80% ✗ $544.3K
Feb 8, 2014 Feb 11, 2014 BIOGEN INC. EVP Research & Development Sell 20.0 -1,636 -14.57% ✗ $516.2K
Feb 1, 2014 Feb 3, 2014 BIOGEN INC. EVP Research & Development Sell 20.0 -1,969 -20.24% ✗ $615.6K